If your child has nephrotic syndrome and it keeps coming back again and again, you are probably tired, worried, and full of questions. You may have already tried steroid tablets. You may have moved on to another medicine like tacrolimus or cyclosporine. And still the swelling returns. Many parents in this situation feel they have run out of choices. There is another option that kidney doctors use in exactly this situation, and it is called rituximab. This article explains what it is, how it works, and what to expect, in simple words.
First, what is nephrotic syndrome?
Your kidneys work like a very fine filter. They clean the blood and let waste and extra water pass out as urine. At the same time, they hold back the useful things your body needs, especially a protein called albumin. In nephrotic syndrome, this filter becomes leaky. Large amounts of protein escape from the blood and go out in the urine.
When protein leaves the blood, water starts moving out of the blood vessels and collects in the tissues. That is why the first sign parents usually notice is puffiness around the eyes in the morning, and later swelling of the legs, feet, or tummy. The urine may look foamy or frothy. The child may gain weight quickly without eating more. It is nobody's fault, and it is not caused by anything you did or did not feed your child.
What does "frequently relapsing" mean?
Most children with nephrotic syndrome respond well to steroid tablets at first. The protein leak stops, the swelling goes down, and the child feels normal again. This is called remission. But in many children the illness comes back after some time. This return is called a relapse.
Doctors use some specific words for the pattern your child follows, and it helps to know them because you will hear them in the consultation room:
- Frequently relapsing: the illness comes back two or more times within six months of the first response, or four or more times in any twelve-month period.
- Steroid dependent: your child stays well only while taking steroids, and relapses when the dose is reduced or soon after it is stopped.
- Steroid resistant: the protein leak does not stop even after a full proper course of steroids.
- CNI dependent or CNI resistant: the same pattern, but now with calcineurin inhibitor medicines such as tacrolimus or cyclosporine.
Children in these groups face a difficult problem. They are not sick all the time, but they are never fully free either. And staying on steroids for years brings its own troubles: poor growth, weight gain and a round face, high blood pressure, bone weakness, mood changes, and a higher chance of infections. This is exactly the situation where doctors start thinking about rituximab.
What is rituximab and how does it work?
Rituximab is not a steroid and not a tablet. It is a medicine given slowly through a drip into a vein, usually in the hospital day-care ward. It belongs to a family of medicines called monoclonal antibodies. Think of it as a very precise tool rather than a broad one.
Our immune system has different types of white blood cells. One type is called the B cell. In many children with frequently relapsing nephrotic syndrome, doctors believe these B cells are part of what keeps triggering the kidney filter to become leaky. Rituximab finds a marker on the surface of B cells, called CD20, and removes those cells from the blood for several months. With the B cells quietened down, the kidney filter often stays sealed, and the relapses stop for a long stretch. Slowly, over months, the body makes new B cells and the effect wears off. This is why some children need a repeat dose later.
For a child who has spent years bouncing between relapse and steroid side effects, the real gift of rituximab is not just remission. It is a chance to grow, to attend school regularly, and to be a child again.
Which children may be helped by it?
Rituximab is not the first medicine anyone reaches for. It is considered when the simpler options have been properly tried and have not given a lasting answer. Your child's kidney specialist may discuss it if the situation matches one of these:
- The illness relapses frequently despite standard treatment.
- Your child can stay well only on steroids and is developing side effects from them.
- Calcineurin inhibitors such as tacrolimus or cyclosporine are not holding the disease, or are causing problems of their own.
- The family and doctors want to reduce the total amount of steroid the child receives over the coming years.
- In some carefully selected children with steroid-resistant disease, as part of a wider plan after a kidney biopsy.
The evidence is strongest for children who are frequently relapsing or steroid dependent. In steroid-resistant disease the results are more mixed, and your doctor will be honest with you about that. Before starting, your child will usually need blood tests, a check for hepatitis B and other infections, a review of vaccinations, and sometimes a kidney biopsy.
What actually happens on the day, and what are the risks?
The infusion is given slowly, often over four to six hours, with a nurse watching your child throughout. Before it starts, your child is given some medicines to reduce reactions. Most children sit through it watching a screen or sleeping. Depending on the plan, one to four doses are given, spaced a week or more apart. Most children go home the same day.
Every real medicine carries risk, and you deserve a straight answer about them. During the drip some children get fever, chills, itching, a rash, or a drop in blood pressure. Slowing the drip usually settles this. Afterwards, the main concern is infection, because part of the immune defence is reduced for some months. Rarely, the body's antibody levels fall low enough to need extra treatment, and very rarely more serious problems have been reported. This is why rituximab is given only under a kidney specialist and why follow-up blood tests matter so much. Live vaccines are avoided for a period around treatment, so tell every doctor your child sees that they have received rituximab.
Caring for your child at home in India
Practical, everyday care matters as much as the medicine. In our climate, dehydration and stomach infections are common, and both can complicate a relapse. Boiled or filtered drinking water, freshly cooked hot food, and careful hand washing before meals are not small things. During monsoon and in crowded seasons, keep your child away from anyone with fever, cough, chickenpox, or measles, and contact your doctor promptly if there is contact.
- Test the first urine of the morning with dipsticks at home if your doctor has advised it, and write the result in a small notebook.
- Weigh your child at the same time each day, ideally in the morning, and note sudden gains.
- Keep salt low during swelling: less pickle, papad, packaged namkeen, and restaurant food.
- Never stop or change steroid doses on your own, even if your child looks completely well.
- Bring the notebook, all medicine strips, and vaccination records to every visit.
- Call the hospital straight away for fever, vomiting, severe tummy pain, breathing difficulty, or a sharp rise in swelling.
What to expect over the coming years
Here is the honest picture. Rituximab is not a permanent cure, and it does not work for every child. What it often does, in children who are frequently relapsing or steroid dependent, is buy a long period of freedom from relapses and allow steroids and other medicines to be reduced or stopped. For a growing child, that period is precious. Some children need a repeat course when the B cells return, and your doctor will monitor for this with blood tests.
Most children with this form of nephrotic syndrome keep normal kidney function into adult life, and many outgrow the relapses as they get older. The road can be long, but it usually leads somewhere good. Ask your child's nephrologist every question you have, including the ones that feel silly. A treatment plan you understand is a treatment plan that works better.
Sources
Frequently asked questions
It is used in some cancers, which worries many parents, but it is not conventional chemotherapy. It does not attack all fast-growing cells. It targets one specific type of immune cell, the B cell. The doses and the way it is used in nephrotic syndrome are different from cancer treatment.
Written by Dr. Chinta Rama Krishna
All ArticlesHave a health concern? Talk to a specialist.
Book a consultation with the Vedanta Hospitals team for advice tailored to you.
Book Appointment




